Vaccine Therapy

High-dose IL-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine
Robert O Dillman, Carol DePriest, Stephanie E McClure

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P208; DOI: 10.1186/2051-1426-1-S1-P208
Vascular normalization: a strategy to recondition the tumor immune microenvironment
Yuhui Huang, Jianping Yuan, Elda Righi, Dan G Duda, Dai Fukumura, Mark C Poznansky, Rakesh K Jain

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P155; DOI: 10.1186/2051-1426-1-S1-P155

Main menu